CSSBSM
JB
SGKT
JS
RTPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
Kyverna Therapeuticskyvernatx.com JC RT SI |
Kyverna is a clinical-stage biopharmaceutical company developing autologous CD19-targeting CAR T-cell therapies to treat B-cell-dr | Emeryville, California | 51-200 | — |
Cartesian Therapeuticscartesiantherapeutics.com |
Cartesian Therapeutics is a biotechnology company founded in 2016 and headquartered in Rockville, Maryland, that is pioneering pot | Rockville, Maryland | 11-50 | — |
Sangamo Therapeuticssangamo.com TG  SKJE |
Sangamo Therapeutics is a biotechnology company developing gene-based therapies using proprietary zinc finger technology, includin | Brisbane, California | 201-1000 | — |
Artiva Biotherapeuticsartivabio.com |
Artiva Biotherapeutics is a clinical-stage biotechnology company developing AlloNK®, a non-genetically modified, cryopreserved all | San Diego, California | 51-200 | — |
Immunovantimmunovant.com  HP JJMW |
Immunovant, Inc. is a clinical-stage immunology company developing anti-FcRn targeted therapies to treat autoimmune diseases, with | New York, New York | 201-1000 | — |
Cabaletta Biocabalettabio.com  DJTF CW |
Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company developing engineered T cell therapies for autoimmune disea | Philadelphia, Pennsylvania | 51-200 | — |
Gilead Sciencesgilead.com DB  AB TM |
Gilead Sciences is a biopharmaceutical company that develops and markets medicines and has a pipeline of clinical programs across | Foster City, California | 5000+ | — |
argenxargenx.com  LTJJ JC |
argenx is a global immunology company that engineers antibody-based medicines for severe autoimmune diseases by partnering with ac | Boston, Massachusetts | 1001-5000 | — |
Nkartatxnkartatx.com |
Nkarta is a clinical-stage biotechnology company developing allogeneic natural killer (NK) cell therapies to treat autoimmune dise | South San Francisco, California | 51-200 | — |
Novartisnovartis.com ETKPXY |
Novartis is an innovative medicines company that discovers and commercializes medicines across cardiovascular, renal and metabolic | — | — | — |
UCBucb.com  IM DA TD |
UCB is a biopharmaceutical company developing and commercializing medicines in immunology and neurology, with five core products i | — | — | — |
Pregenenbluebirdbio.com |
Genetix Biotherapeutics (formerly bluebird bio) is a privately held, Boston-area gene therapy company developing first-in-class, o | Seattle, Washington | 1-10 | — |
Celularitycelularity.com |
Celularity (NASDAQ: CELU) is a Florham Park, New Jersey biotechnology company developing and commercializing allogeneic, cryoprese | Florham Park, New Jersey | 51-200 | — |
Celgenecelgene.com |
Biotechnology Research | San Diego, California | 11-50 | — |
AstraZenecaastrazeneca.com  GS SCSG |
AstraZeneca is a research-based bioPharmaceutical company that develops and manufactures medicines, vaccines, and oncology treatme | — | — | — |
Caribou Biosciencescariboubio.com |
Caribou Biosciences is a clinical-stage biopharmaceutical company developing off-the-shelf, allogeneic CAR-T cell therapies using | Berkeley, California | 51-200 | — |
Adaptimmuneadaptimmune.com |
Adaptimmune (ADAPY) is a biopharmaceutical company developing cell therapies to treat cancer, with its announced product TECELRA ( | — | — | — |
Allogene Therapeuticsallogene.com |
Allogene Therapeutics is a clinical-stage biotechnology company developing investigational allogeneic chimeric antigen receptor T | South San Francisco, California | 201-1000 | — |
Hansohhansoh.cn |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. is a Chinese pharmaceutical company established in July 1995 that operates across R& | Lianyungang, Jiangsu | 201-1000 | — |
Blueprintmedicineblueprintmedicine.com |
— | — | — | |
Crispertherapeuticscrispertherapeutics.com |
— | — | — | |
Kite Pharmakitepharma.com |
Kite, a Gilead Company, is a biotechnology research organization that develops CAR T-cell therapy to treat hematologic malignancie | Santa Monica, California | 1001-5000 | — |
Kitekite.com |
Kite is a San Francisco-based software company founded in 2014 that used AI to help developers write code. The company announced i | San Francisco, California | 51-200 | — |
Autolusautolus.com |
Autolus is a clinical-stage biopharmaceutical company developing CAR T cell therapies for patients with cancer and autoimmune dise | — | — | — |
Precisionbiosciencesprecisionbiosciences.com |
Precision BioSciences (Nasdaq: DTIL) is a clinical-stage gene editing company based in Durham, North Carolina, developing in vivo | Durham, North Carolina | 51-200 | — |
Carttherapeuticscarttherapeutics.com |
— | — | — | |
| Run live for more | ||||
Kyverna is a clinical-stage biopharmaceutical company developing autologous CD19-targeting CAR T-cell therapies to treat B-cell-driven autoimmune diseases, with its lead candidate miv-cel (KYV-101) advancing through registrational trials in stiff person syndrome and generalized myasthenia gravis.
Companies like Kyverna Therapeutics include Cartesian Therapeutics, Sangamo Therapeutics, Artiva Biotherapeutics, Immunovant, Cabaletta Bio. See the full list of 24 competitors and alternatives above.
Kyverna Therapeutics has approximately 51-200 employees and is in the Biotechnology Research industry.
Kyverna Therapeutics is headquartered in Emeryville, California.
Kyverna Therapeutics operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at Kyverna Therapeutics are listed above, including leaders across executive, finance, sales and operations.